$417 Million is the total value of SECTOR GAMMA AS's 31 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LLY | Sell | LILLY ELI & CO | $46,320,000 | +12.8% | 786,947 | -2.2% | 11.11% | +0.3% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $27,186,000 | -12.8% | 2,010,800 | -22.5% | 6.52% | -22.5% |
| JNJ | Sell | JOHNSON & JOHNSON | $18,443,000 | -2.5% | 187,750 | -9.1% | 4.42% | -13.4% |
| CAH | Sell | CARDINAL HEALTH INC | $14,395,000 | -27.1% | 205,700 | -30.4% | 3.45% | -35.2% |
| CBST | Sell | CUBIST PHARMACEUTICALS INC | $12,171,000 | +0.4% | 166,390 | -5.5% | 2.92% | -10.8% |
| A | Sell | AGILENT TECHNOLOGIES INC | $11,743,000 | -27.4% | 210,000 | -25.8% | 2.82% | -35.5% |
| LPNT | Sell | LIFEPOINT HOSPITALS INC | $11,068,000 | -3.0% | 202,900 | -6.1% | 2.65% | -13.8% |
| AUXL | Sell | AUXILIUM PHARMACEUTICALS INC | $7,720,000 | -19.5% | 284,020 | -38.6% | 1.85% | -28.4% |
| ESRX | Sell | EXPRESS SCRIPTS INC | $6,510,000 | -36.9% | 86,700 | -40.9% | 1.56% | -43.9% |
| MDCO | Sell | MEDICINES CO | $3,625,000 | -67.4% | 127,550 | -55.7% | 0.87% | -71.0% |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -136,800 | -100.0% | -0.65% | – |
| OMI | Exit | OWENS & MINOR INC NEW | $0 | – | -80,084 | -100.0% | -0.79% | – |
| HNT | Exit | HEALTH NET INC | $0 | – | -145,000 | -100.0% | -1.16% | – |
| AGN | Exit | ALLERGAN INC | $0 | – | -45,000 | -100.0% | -1.35% | – |
| BIIB | Exit | BIOGEN IDEC INC | $0 | – | -20,000 | -100.0% | -1.51% | – |
| STJ | Exit | ST JUDE MED INC | $0 | – | -106,000 | -100.0% | -1.77% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -243,150 | -100.0% | -1.92% | – |
| FRX | Exit | FOREST LABS INC | $0 | – | -440,349 | -100.0% | -7.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-08 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.